Breaking News

Insurers still lag behind mental health parity laws

Not rendering correctly? View this email as a web page here.

Texas Medical Association continuing opposition to No Surprises Act ruling for determining out-of-network pricing

By Emma Bardin Wednesday, January 26, 2022 1:55 AM

The Texas Medical Association (TMA) filed a brief on Monday to further oppose the ruling on the No Suprises Act that currently allows aribtrators to use the average in-network rate to determine out-of-network cost.

Read more »

Sierra succeeds where Gilead missed; FDA filing now planned for blood cancer drug

By Frank Vinluan Tuesday, January 25, 2022 5:03 PM

Sierra Oncology myelofibrosis drug momelotinib achieved the main and secondary goals of a pivotal test and the biotech now plans to seek FDA approval. Sierra acquired momelotinib from Gilead Sciences after that company stopped work on the drug due to mixed results in Phase 3 testing.

Read more »

What is inflation's impact on clinical trials?

By Katie Rothstein Tuesday, January 25, 2022 4:46 PM

Basic organic chemicals used for the preparation of new medications cost over 54.8% more than they did 12 months ago. Further, with schools and daycare facilities either going fully remote and/or closed, many parents and caregivers had to stay at home, eliminating their availability for study participation.

Read more »

Following Janssen flu deal, Leyden Labs gets $140M led by Casdin Capital and GV

By Frank Vinluan Tuesday, January 25, 2022 12:55 PM

Leyden Labs is developing nasal spray medicines to prevent respiratory viral infections. The company's Series B round of funding follows a licensing deal that gives the biotech rights to a Janssen antibody designed to address the two types of influenza that cause seasonal flu.

Read more »

Examining the value-based care approach: How improved data models and analysis can remedy inequities

By Ben Alsdurf Tuesday, January 25, 2022 8:05 AM

By building greater understanding of context and flexibility into alternative payment models and enabling providers to make data-driven choices, we can begin to address inequities burdening VBC and help ensure APMs remain viable and enticing for healthcare providers.

Read more »

   

No comments